Evidence map›Paper›PMID 41150366›Full record

ArticleTropical medicine and infectious disease2025

Comparison of Clinical, Epidemiological, Haematological, and Biochemical Characteristics in Serologically Confirmed and Suspected Cases of Tularemia.

Nurten Nur Aydın, Murat Aydın, Ömer Karaşahin

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Clinical review of tularemia cases, evaluation of treatment approaches: single-center retrospective study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nurten Nur AydınDepartment of Infectious Diseases and Clinical Microbiology, Erzurum Regional Training and Research Hospital, Erzurum 25080, Turkey.ORCID 0000-0003-4138-2490
Murat AydınDepartment of Infectious Diseases and Clinical Microbiology, Erzurum Regional Training and Research Hospital, Erzurum 25080, Turkey.ORCID 0000-0002-0167-0802
Ömer KaraşahinDepartment of Infectious Diseases and Clinical Microbiology, Erzurum Regional Training and Research Hospital, Erzurum 25080, Turkey.ORCID 0000-0002-4245-1534

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTularemia is a zoonotic infection caused by

methodsThis retrospective study included adults (≥18 years) who presented to the Infectious Diseases Outpatient Clinic between 2016 and 2024 with suspected tularemia and were tested using a microagglutination test (MAT). Patients with a positive MAT (≥1:160) or a fourfold titre increase were classified as tularemia cases, while seronegative patients were defined as tularemia-like cases. Demographic data, clinical symptoms, epidemiological risk factors, and laboratory findings were compared between the two groups.

resultsA total of 105 patients were included, 54 (51.4%) of whom were diagnosed with tularemia. The duration from symptom onset to healthcare presentation was significantly longer in tularemia cases (20.3 ± 5.7 vs. 15.7 ± 6.2 days;

conclusionsTularemia cases are associated with particular epidemiological risk factors and oropharyngeal symptoms. A thorough epidemiological evaluation is crucial for diagnosis, and enhancing awareness among healthcare providers and the public may facilitate earlier recognition and management.

Indexed as

lymphadenopathyMATretrospective studytularemiaTurkeyzoonotic infections

Identifiers

PMID41150366
PMCPMC12567999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.